Synchrony Pharmaceutical Private Limited
About Synchrony Pharmaceutical Private Limited
Data last updated:
Synchrony Pharmaceutical Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 21 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33302DL2020PTC368309.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rajesh Kumar Srivastava and Arpita Srivastava.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No.280 Ground Floor Blk – Bb Jj Colony Wazirpur, Delhi, India – 110052.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.32 Cr, a growth of 33% compared to the previous year. For the same year it recorded a net profit of ₹2.47 Lakh (net margin 1.9%) and EBITDA of ₹5.34 Lakh (EBITDA margin 4%). Revenue has grown at a compounded annual rate (CAGR) of 348% over three years.
As per MCA filings, the company has open charges of ₹16 Lakh on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressHouse No.280 Ground Floor Blk – Bb Jj Colony Wazirpur, Delhi, India – 110052
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Synchrony Pharmaceutical Private Limited
The main business activity of Synchrony Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Synchrony Pharmaceutical Private Limited FY 2025 filings available
Synchrony Pharmaceutical Private Limited reported revenue of ₹1.32 Cr (up 33% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Synchrony Pharmaceutical Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 348% over three years, including 33% growth in the latest year. EBITDA rose 31% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Synchrony Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹5.34 Lakh | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.47 Lakh | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Synchrony Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 4% | •••• | •••• | •••• |
| Net Profit Margin | 1.9% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Synchrony Pharmaceutical are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Synchrony Pharmaceutical Private Limited
Synchrony Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale trade, except of motor vehicles and motorcycles). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Umar Agro India Private Limited | ₹1.32 Cr (FY 2025) | •••• | •••• | -92.0% | •••• | Anjangaon, Maharashtra, India |
| VK Tiles and Bath Fittings Private Limited | ₹1.32 Cr (FY 2024) | •••• | •••• | -10.0% | •••• | Delhi, India |
| Laktas Wire Mesh Private Limited | ₹1.32 Cr (FY 2025) | •••• | •••• | 37.0% | •••• | Mumbai, Maharashtra, India |
| Star Energy Limited | ₹1.32 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Mumbai, Maharashtra, India |
| Alphahealth Lifesciences Private Limited | ₹1.32 Cr (FY 2025) | •••• | •••• | 273.0% | •••• | Ambarnath, Maharashtra, India |
| Synchrony Pharmaceutical Private Limited this company | ₹1.32 Cr (FY 2024) | •••• | •••• | 33.0% | •••• | Delhi, India |
| Ayka Tradings Private Limited | ₹1.32 Cr (FY 2025) | •••• | •••• | 24.0% | •••• | New Delhi, Delhi, India |
| Infinity Logic Solutions Private Limited | ₹1.32 Cr (FY 2025) | •••• | •••• | •••• | Barasat, West Bengal, India | |
| Balin Healthcare Private Limited | ₹1.32 Cr (FY 2025) | •••• | •••• | 46.0% | •••• | Navi Mumbai, Maharashtra, India |
| Ibo Infotech Private Limited | ₹1.32 Cr (FY 2025) | •••• | •••• | 1196.0% | •••• | Ernakulam, Kerala, India |
| Micro Agencies Private Limited | ₹1.32 Cr (FY 2025) | •••• | •••• | 30.0% | •••• | Kolkata, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Synchrony Pharmaceutical by revenue in the same principal business activity (Wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Synchrony Pharmaceutical Private Limited
Synchrony Pharmaceutical has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Kumar Srivastava | Director | 13 Dec 2021 | 4 Years 10 Months | Current |
| Arpita Srivastava | Director | 21 Aug 2020 | 6 Years 1 Months | Current |
Charges & Borrowings of Synchrony Pharmaceutical Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 May 2021 | State Bank of India | ₹16 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Synchrony Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Synchrony Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Synchrony Pharmaceutical Private Limited
Synchrony Pharmaceutical Private Limited has 4 board changes on record since 2020: 2 appointments and 2 cessations. The latest: Rajesh Kumar Srivastava ceased to be Additional Director on 29 Sep 2022.
Credit Ratings, Litigation & Regulatory Alerts for Synchrony Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Synchrony Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Synchrony Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Synchrony Pharmaceutical Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Synchrony Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Synchrony Pharmaceutical Private Limited
Synchrony Pharmaceutical is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 21 August 2020 (6+ years old) and is registered under CIN U33302DL2020PTC368309.
Synchrony Pharmaceutical reported revenue of ₹1.32 Cr for FY 2024 (up 33% YoY).
Synchrony Pharmaceutical has 2 current directors:
- Rajesh Kumar Srivastava - Director
- Arpita Srivastava - Director
Synchrony Pharmaceutical reported a net profit of ₹2.47 Lakh (net margin 1.9%) and EBITDA of ₹5.34 Lakh (EBITDA margin 4%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Synchrony Pharmaceutical is 348% over three years. In the latest year (FY 2024) revenue rose 33%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Synchrony Pharmaceutical is U33302DL2020PTC368309. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Synchrony Pharmaceutical was incorporated on 21 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Synchrony Pharmaceutical by revenue are Umar Agro India Private Limited, VK Tiles and Bath Fittings Private Limited, Laktas Wire Mesh Private Limited, Star Energy Limited, Alphahealth Lifesciences Private Limited and 5 more, all in the same principal business activity (Wholesale trade, except of motor vehicles and motorcycles).
Rajesh Kumar Srivastava ceased to be Additional Director on 29 Sep 2022. Sarvesh Tripathi ceased to be Director on 15 Dec 2021. Rajesh Kumar Srivastava was appointed as Director on 13 Dec 2021. Synchrony Pharmaceutical has 4 board changes on record in total.
The registered office of Synchrony Pharmaceutical is at House No.280 Ground Floor Blk – Bb Jj Colony Wazirpur, Delhi, India – 110052.
Synchrony Pharmaceutical has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh.